Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Bilcare

₹63.5 2 | 3.3%

Market Cap ₹149 Cr.

Stock P/E 6.3

P/B 0.8

Current Price ₹63.5

Book Value ₹ 75.3

Face Value 10

52W High ₹95.4

Dividend Yield 0%

52W Low ₹ 42.5

Overview Inc. Year: 1987Industry: Plastic Products

Bilcare Ltd is a global leader in providing innovative packaging, branding, and authentication solutions for pharmaceutical, healthcare, and FMCG (Fast-Moving Consumer Goods) industries. Established in 1987, the company is renowned for its advanced packaging technologies that ensure product safety, authenticity, and brand protection. Bilcare offers a comprehensive range of services, including blister packaging, specialized labeling, and digital authentication solutions. With a strong focus on research and development, Bilcare has pioneered novel packaging concepts to combat counterfeiting and enhance supply chain efficiency. The company's commitment to quality, innovation, and customer satisfaction has solidified its position as a trusted partner for businesses seeking cutting-edge packaging and authentication solutions in today's competitive market.

Read More..

Bilcare Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Bilcare Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 204 208 256 248 254 246 234 182 190 175
Other Income 2 0 9 3 3 0 4 4 10 4
Total Income 205 208 264 251 257 246 238 186 200 179
Total Expenditure 188 194 237 232 240 234 219 169 173 158
Operating Profit 17 14 27 19 17 12 18 17 27 21
Interest 18 16 17 16 16 16 11 19 20 21
Depreciation 9 10 9 9 9 10 9 11 10 11
Exceptional Income / Expenses 33 0 -4 -1 7 -7 227 -1 -2 0
Profit Before Tax 23 -12 -3 -7 -2 -20 225 -13 -5 -10
Provision for Tax -1 -0 1 -1 1 -1 147 -0 7 3
Profit After Tax 23 -11 -3 -6 -3 -19 78 -13 -12 -14
Adjustments -1 -2 -2 -1 -3 0 -32 5 5 7
Profit After Adjustments 22 -14 -6 -7 -6 -19 46 -8 -8 -7
Adjusted Earnings Per Share 9.5 -5.9 -2.5 -2.8 -2.4 -8 19.6 -3.4 -3.2 -2.9

Bilcare Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 3547 3062 2692 2603 2633 2778 2997 1827 623 845 982 781
Other Income 20 18 46 30 39 34 60 97 18 15 10 22
Total Income 3567 3080 2738 2633 2672 2813 3057 1924 641 859 992 803
Total Expenditure 3175 2823 2507 2396 2445 2621 2829 1782 572 784 925 719
Operating Profit 392 257 231 237 227 192 229 142 69 75 67 83
Interest 167 217 236 151 176 249 283 174 76 69 60 71
Depreciation 148 141 191 164 177 416 378 239 46 39 38 41
Exceptional Income / Expenses 0 0 0 -117 70 267 0 157 27 29 227 224
Profit Before Tax 76 -101 -196 -194 -56 -207 -433 -114 -25 -4 196 197
Provision for Tax 19 23 -16 -112 24 -8 21 -15 -14 0 146 157
Profit After Tax 57 -124 -180 -82 -80 -199 -453 -99 -11 -4 50 39
Adjustments -18 11 -36 -3 -5 -2 -4 -5 -10 -8 -35 -15
Profit After Adjustments 40 -113 -216 -85 -85 -201 -458 -104 -21 -13 15 23
Adjusted Earnings Per Share 22.2 -52.5 -76.3 -36 -35.9 -85.4 -194.3 -44 -9 -5.3 6.4 10.1

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 16% -19% -19% -12%
Operating Profit CAGR -11% -22% -19% -16%
PAT CAGR 0% 0% 0% -1%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 43% 6% 25% 1%
ROE Average 36% 6% -154% -77%
ROCE Average 32% 16% 9% 6%

Bilcare Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 1325 1324 1096 713 614 400 -70 108 86 75 531
Minority's Interest 54 53 49 59 62 63 64 68 78 86 173
Borrowings 1769 1882 2085 1893 1801 741 745 559 530 537 515
Other Non-Current Liabilities 281 244 144 198 235 219 279 -24 -52 -88 36
Total Current Liabilities 989 866 966 758 745 1978 2069 311 313 403 333
Total Liabilities 4419 4368 4340 3620 3457 3402 3087 1023 955 1013 1588
Fixed Assets 1493 2126 1926 2432 2402 2179 2005 534 493 465 1045
Other Non-Current Assets 914 318 367 282 267 290 201 124 125 128 205
Total Current Assets 2012 1924 2047 907 788 933 882 365 337 421 338
Total Assets 4419 4368 4340 3620 3457 3402 3087 1023 955 1013 1588

Bilcare Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 173 94 106 106 73 90 77 76 41 32 14
Cash Flow from Operating Activities 227 314 -315 177 300 98 206 256 72 41 -7
Cash Flow from Investing Activities -966 -351 247 -358 -129 -203 -104 1309 2 -4 36
Cash Flow from Financing Activities 661 48 119 149 -155 91 -103 -1600 -83 -55 -19
Net Cash Inflow / Outflow -78 12 50 -32 16 -13 -1 -35 -9 -18 10
Closing Cash & Cash Equivalent 94 106 156 73 90 77 76 41 32 14 24

Bilcare Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 22.23 -52.47 -76.34 -36.04 -35.9 -85.43 -194.34 -43.97 -8.95 -5.35 6.39
CEPS(Rs) 87.34 7.11 4.81 34.58 41.26 92.2 -31.82 59.36 14.59 14.82 37.38
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 562.95 562.25 465.54 302.72 260.59 169.83 -29.66 45.99 36.66 31.91 87.65
Core EBITDA Margin(%) 10.49 7.81 6.89 7.8 7.03 5.64 5.62 2.49 8.18 7.15 5.77
EBIT Margin(%) 6.86 3.79 1.49 -1.65 4.49 1.5 -4.99 3.31 8.13 7.66 26.09
Pre Tax Margin(%) 2.14 -3.31 -7.27 -7.34 -2.09 -7.43 -14.43 -6.22 -4.01 -0.5 19.98
PAT Margin (%) 1.61 -4.06 -6.68 -3.1 -2.98 -7.14 -15.12 -5.42 -1.79 -0.52 5.12
Cash Profit Margin (%) 5.8 0.55 0.42 3.07 3.62 7.78 -2.5 7.65 5.52 4.13 8.97
ROA(%) 1.4 -2.83 -4.13 -2.07 -2.26 -5.81 -13.97 -4.82 -1.13 -0.44 3.86
ROE(%) 4.38 -9.38 -14.86 -9.09 -12.03 -39.29 -274.69 -515.03 -11.48 -5.4 35.67
ROCE(%) 7.96 3.36 1.16 -1.4 4.4 1.64 -6.38 4.01 6.41 8.46 31.84
Receivable days 112.28 113.79 122.04 80.67 31.16 32.61 36.51 41.68 76.83 80.87 75.84
Inventory Days 49.99 55.07 59.89 55.79 49.63 46.03 45.19 44.58 52.13 51.27 41
Payable days 64.5 65.93 64.89 79.49 81.26 89.55 83.11 75.84 89.29 82.96 82.4
PER(x) 3.79 0 0 0 0 0 0 0 0 0 6.8
Price/Book(x) 0.15 0.09 0.1 0.14 0.2 0.31 -0.92 0.33 1.57 2.19 0.5
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.62 0.7 0.84 0.81 0.77 0.76 0.75 0.37 1.21 0.96 0.72
EV/Core EBITDA(x) 5.63 8.38 9.78 8.91 8.87 11.05 9.81 4.76 10.91 10.86 10.58
Net Sales Growth(%) -2.61 -13.67 -12.07 -3.32 1.16 5.53 7.87 -39.04 -65.92 35.65 16.2
EBIT Growth(%) -31.03 -52.38 -65.45 -209.12 375.22 -65.21 -457.62 140.43 -16.35 27.82 295.77
PAT Growth(%) -59.14 -317.15 -44.66 54.28 2.9 -149.48 -127.66 78.15 88.72 60.95 1251.22
EPS Growth(%) -61.68 -336.04 -45.51 52.79 0.38 -137.92 -127.5 77.37 79.64 40.26 219.5
Debt/Equity(x) 1.59 1.62 2.11 2.98 3.28 5.22 -32.5 6.53 7.85 9.18 3.09
Current Ratio(x) 2.03 2.22 2.12 1.2 1.06 0.47 0.43 1.17 1.08 1.04 1.01
Quick Ratio(x) 1.58 1.68 1.69 0.67 0.62 0.28 0.25 0.93 0.75 0.71 0.76
Interest Cover(x) 1.45 0.53 0.17 -0.29 0.68 0.17 -0.53 0.35 0.67 0.94 4.27
Total Debt/Mcap(x) 10.59 18.81 22.04 21.48 16.18 16.63 35.44 20.01 4.99 4.2 6.23

Bilcare Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 30.01 30.01 30.01 30.01 30.01 30.01 30.01 30.01 30.01 30.01
FII 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04
DII 0 0 0 0 0 0 0 0 0 0
Public 69.94 69.94 69.94 69.94 69.94 69.94 69.94 69.94 69.94 69.94
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Stock is trading at 0.8 times its book value
  • Debtor days have improved from 82.96 to 82.4days.
  • Company has reduced debt.

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend.
  • Promoter holding is low: 30.01%.
  • Company has a low return on equity of 6% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Bilcare News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....